MedPath

Ayurvedic Treatment Protocol in the management of Infertility associated with Obesity.

Phase 2
Conditions
Health Condition 1: N970- Female infertility associated withanovulation
Registration Number
CTRI/2023/04/051297
Lead Sponsor
Institute of Teaching and Research in Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patient having BMI more than 25 kg per meter square.

2. Patients who have completed active married life of minimum 1 year duration and suffering from Infertility with 2 and more consecutive Anovulatory Cycle.

3. Both Primary and Secondary Infertile Patients having Anovulatory Cycle or with Immature Ovarian Follicle.

4. Patient Eligible and Willing for Udvartana and Virechana Karma.

5. Patient Willing To Participate In Trial

Exclusion Criteria

1. Female Patients having age less than 20 years and more than 40 years.

2. Patient with Infectious Disease of the Reproductive Tract like Tuberculosis and Sexually Transmitted Disease.

3. Organic Lesions of the Reproductive Tract like Carcinoma and Congenital Deformity.

4. Patients with history of Cardiac Diseases, Uncontrolled Diabetes ( RBS more than 200 mg/dl) and Hypertension (Systolic BP more than 160 and Diastolic more than 100 mmHg) and Tuberculosis.

5. Patient with Hepatitis B and Hepatitis C.

6. Patient not eligible and willing for Udvartana and Virechna Karma.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. It Is Expected That The Trial Drug Will Induce Ovulation. <br/ ><br>2. It Is Expected That The Trial Drug Will Reduce BMI Of The Patient.Timepoint: 3 Months
Secondary Outcome Measures
NameTimeMethod
Trial Drug Will Cure Menstrual Abnormalities Associated With Anovulation Like Irregular, Scanty, Excessive Menstruation And Dysmenorrhea.Timepoint: 3 months
© Copyright 2025. All Rights Reserved by MedPath